Clinical Trial Update: Conversion of Maintenance Prograf to Envarsus in Liver Transplant Recipients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update describes converting maintenance tacrolimus from Prograf to Envarsus in liver transplant recipients, with enrollment by invitati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplant Rejection

Drugs mentioned

• Envarsus (tacrolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Liver Transplant Rejection, Immune System Suppression | Phase 4 | Status: ENROLLING_BY_INVITATION